Literature DB >> 4087201

Evaluation of nonlinear regression with extended least squares: simulation study.

A H Thomson, A W Kelman, B Whiting.   

Abstract

A new approach to nonlinear least-squares regression analysis using extended least squares (ELS) was compared with three conventional methods: ordinary least squares (OLS); weighted least squares 1/C (WLS-1) and weighted least squares 1/C2 (WLS-2). With Monte Carlo simulation techniques, 3 X 200 data sets were constructed with constant proportional error (5, 10, and 15% error) and 3 X 200 with constant additive error (0.05, 0.10, and 0.15 g/mL) from an initial (perfect) data set based on known parameters. Two sampling strategies were employed: one with 17 time points and one with 10 time points. All data sets were fitted by each of the four methods, and parameter estimation bias was assessed by comparing the mean parameter estimate with the known value. The relative precision of each method was investigated by examination of the absolute deviations of each individual parameter estimate from the known value. ELS performed as well as the appropriate weighting scheme (WLS-2 for constant proportional error sets and OLS for constant additive error sets) and was superior with regard to both bias and precision to less appropriate methods.

Mesh:

Year:  1985        PMID: 4087201     DOI: 10.1002/jps.2600741215

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  A comparison of methods for estimating individual pharmacokinetic parameters.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Pharmacokinetic parameter estimations by minimum relative entropy method.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

3.  Pharmacokinetics of human growth hormone releasing factor (hGRF-44 NH2) in normal men after intravenous administration of a large range of doses.

Authors:  P Girard; R Cohen; G Sassolas; C Harthe; P Cabrera; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.